UNKNOWN VLOC PRODUCT
Report
- Report Number
- 1219930-2019-07208
- Event Type
- Death
- Date Received
- December 27, 2019
- Date of Event
- October 1, 2018
- Report Date
- December 27, 2019
- Manufacturer
- COVIDIEN LP LLC NORTH HAVEN
- Product Code
- GAM
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- OTHER
Narratives
TITLE COMPARISON OF INTRACORPOREAL AND EXTRACORPOREAL URINARY DIVERSIONS AFTER LAPAROSCOPIC RADICAL CYSTECTOMY IN FEMALES WITH BLADDER CANCER SOURCE WORLD JOURNAL OF SURGICAL ONCOLOGY 2019 (17:161) DATE OF ONLINE PUBLICATION: 12 SEPTEMBER 2019. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
ACCORDING TO THE LITERATURE SOURCE OF STUDY PERFORMED FROM FEBRUARY 2008 TO OCTOBER 2018, THE ARTICLE COMPARES THE PERI-OPERATIVE OUTCOMES OF FEMALES UNDERGOING LAPAROSCOPIC INTRACORPOREAL URINARY DIVERSIONS (ICUD) AND EXTRACORPOREAL URINARY DIVERSIONS (ECUD) AFTER LAPAROSCOPIC RADICAL CYSTECTOMIES (LRC). INCLUDED IN THIS STUDY ARE 19 PATIENTS IN BOTH THE ECUD GROUP AND THE ICUD GROUP FOR A TOTAL OF 38 PATIENTS. SEVEN PATIENTS HAD DISEASE METASTASES (ECUD 2 OUT OF 19, ICUD 5 OUT OF 19; P = 0.405) AND 5 DIED AFTER FOLLOWUP (ECUD 3 OUT OF 19, ICUD 2 OUT OF 19). INTRAPROCEDURE, THE DORSAL VEIN COMPLEX (DVC) WAS LIGATED WITH 2-0 V-LOC SUTURES TO AVOID USING INSTRUMENTS THAT CAUSED HEAT DAMAGE. POST PROCEDURE, 1 PATIENT (5%) HAD A CLAVIEN GRADE V COMPLICATION WHO LATER DIED DUE TO MULTIPLE ORGAN FAILURE RESULTING FROM A MYOCARDIAL INFARCTION WITHIN 30 DAYS. WU ET AL. WORLD JOURNAL OF SURGICAL ONCOLOGY (2019): LIYUAN WU1, FEIYA YANG1*, LIMING SONG2, ZEJUN XIAO1, SUJUN HAN1, SONG WU3, SAI LIU2, QINGBAO HE2 AND NIANZENG XING.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1319813 | UNKNOWN VLOC PRODUCT | SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID | GAM | COVIDIEN LP LLC NORTH HAVEN | UNKNOWN VLOC PRODUCT |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 65 YR | Death |